Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 250

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Genetic and epigenetic stability of human pluripotent stem cells

Lund, Riikka J., Närvä, Elisa, Lahesmaa, Riitta · 2012 · Nature Reviews Genetics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrg3271

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 96

  1. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998). · DOI · Paper page
  2. Vazin, T. & Freed, W. J. Human embryonic stem cells: derivation, culture, and differentiation: a review. Restor. Neurol. Neurosci. 28, 589–603 (2010).
  3. Robinton, D. A. & Daley, G. Q. The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295–305 (2012). · DOI · Paper page
  4. Zhu, H., Lensch, M. W., Cahan, P. & Daley, G. Q. Investigating monogenic and complex diseases with pluripotent stem cells. Nature Rev. Genet. 12, 266–275 (2011). · DOI
  5. Schwartz, S. D. et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713–720 (2012). · DOI · Paper page
  6. Draper, J. S. et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nature Biotech. 22, 53–54 (2004). · DOI · Paper page
  7. Cowan, C. A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353–1356 (2004). · DOI · Paper page
  8. Baker, D. E. et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nature Biotech. 25, 207–215 (2007). · DOI · Paper page
  9. Harrison, N. J., Baker, D. & Andrews, P. W. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int. J. Androl. 30, 275–281 (2007). · DOI
  10. Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521–531 (2010). · DOI · Paper page
  11. Martins-Taylor, K. et al. Recurrent copy number variations in human induced pluripotent stem cells. Nature Biotech. 29, 488–491 (2011). This was a high-resolution study that identified genomic stability of 32 iPSC lines in culture. It also identified recurrent CNV sites after extended time in culture. · DOI · Paper page
  12. Ben-David, U., Mayshar, Y. & Benvenisty, N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 9, 97–102 (2011). · DOI · Paper page
  13. Maitra, A. et al. Genomic alterations in cultured human embryonic stem cells. Nature Genet. 37, 1099–1103 (2005). · DOI · Paper page
  14. Lefort, N. et al. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nature Biotech. 26, 1364–1366 (2008). · DOI · Paper page
  15. Spits, C. et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nature Biotech. 26, 1361–1363 (2008). · DOI · Paper page
  16. Wu, H. et al. Copy number variant analysis of human embryonic stem cells. Stem Cells 26, 1484–1489 (2008). · DOI
  17. Werbowetski-Ogilvie, T. E. et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nature Biotech. 27, 91–97 (2009). · DOI · Paper page
  18. Närvä, E et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nature Biotech. 28, 371–377 (2010). This was one of the first high-resolution studies examining CNVs and loss of heterozygosity in 17 karyotypically normal or abnormal hESC lines maintained in different laboratories. · DOI · Paper page
  19. Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58–62 (2011). This study conducted high-resolution copy number analysis of reprogramming-induced changes of 22 iPSC lines. It also identified genetic mosaicism in the newly established early-passage iPSCs. · DOI · Paper page
  20. International Stem Cell Initiative. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotech. 29, 1132–1144 (2011). This study looked at genetic and epigenetic changes in 125 hESC and 11 hiPSC lines with different origins. SNV analysis revealed accumulation of changes in some of the lines and hotspots for changes. The authors studied the methylation status of ~1,500 loci (Polycomb group targets) in early- and late-passage hESCs. Unstable methylation patterns were observed for some loci, whereas others remained stable status; no consistent hotspots were observed. · DOI · Paper page
  21. Elliott, A. M., Elliott, K. A. & Kammesheidt, A. High resolution array-CGH characterization of human stem cells using a stem cell focused microarray. Mol. Biotechnol. 46, 234–242 (2010). · DOI
  22. Chin, M. H. et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111–123 (2009). · DOI · Paper page
  23. Hyslop, L. et al. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 23, 1035–1043 (2005). · DOI · Paper page
  24. Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033–1038 (2010). · DOI · Paper page
  25. Takahashi, K., Okita, K., Nakagawa, M. & Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nature Protoc. 2, 3081–3089 (2007). · DOI · Paper page
  26. Kim, D. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472–476 (2009). · DOI · Paper page
  27. Woltjen, K. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766–770 (2009). · DOI · Paper page
  28. Miyoshi, N. et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8, 633–638 (2011). · DOI · Paper page
  29. Ji, J. et al. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells 30, 435–440 (2012). · DOI · Paper page
  30. Young, M. A. et al. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 10, 570–582 (2012). · DOI · Paper page
  31. Hardarson, T. et al. A morphological and chromosomal study of blastocysts developing from morphologically suboptimal human pre-embryos compared with control blastocysts. Hum. Reprod. 18, 399–407 (2003). · DOI
  32. Vanneste, E. et al. Chromosome instability is common in human cleavage-stage embryos. Nature Med. 15, 577–583 (2009). · DOI · Paper page
  33. Ferguson-Smith, A. C. Genomic imprinting: the emergence of an epigenetic paradigm. Nature Rev. Genet. 12, 565–575 (2011). · DOI · Paper page
  34. Meissner, A. Epigenetic modifications in pluripotent and differentiated cells. Nature Biotech. 28, 1079–1088 (2010). · DOI · Paper page
  35. van den Berg, I. M. et al. X chromosome inactivation is initiated in human preimplantation embryos. Am. J. Hum. Genet. 84, 771–779 (2009). · DOI · Paper page
  36. Piedrahita, J. A. The role of imprinted genes in fetal growth abnormalities. Birth Defects Res. A. Clin. Mol. Teratol. 91, 682–692 (2011). · DOI
  37. Pick, M. et al. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27, 2686–2690 (2009). · DOI · Paper page
  38. Nazor, K. L. et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10, 620–634 (2012). This study carried out genome-wide microarray-based DNA methylation and transcriptome analysis of 136 hESCs, 69 hiPSCs, 80 somatic samples from 17 tissues and 50 primary cultures. It identified cell- and tissue-specific DNA methylation patterns and reported variation and instability in XCI and imprinted genes in pluripotent cells. · DOI · Paper page
  39. Bock, C. et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439–452 (2011). This paper describes DNA methylation and transcriptome analysis on 20 hESC and 12 iPSC lines. Variation was observed, including in developmental genes. Changes were stable throughout passages, were enriched in sex chromosomes and were found to affect the differentiation capacity. · DOI · Paper page
  40. Nishino, K. et al. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet. 7, e1002085 (2011). This study monitored DNA methylation profiles during in vitro maintenance of 22 hiPSC lines derived from different sources and compared to five hESC lines. Observed stochastic and random aberrant methylation patterns particularly during the early passages. The hiPSCs become gradually more similar to hESC lines during prolonged culturing of hiPSCs. · DOI · Paper page
  41. Rugg-Gunn, P. J., Ferguson-Smith, A. C. & Pedersen, R. A. Epigenetic status of human embryonic stem cells. Nature Genet. 37, 585–587 (2005). · DOI · Paper page
  42. Kim, K. P. et al. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res. 17, 1731–1742 (2007). · DOI
  43. Sun, B. W. et al. Temporal and parental-specific expression of imprinted genes in a newly derived Chinese human embryonic stem cell line and embryoid bodies. Hum. Mol. Genet. 15, 65–75 (2006). · DOI
  44. Bruck, T. & Benvenisty, N. Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res. 6, 187–193 (2011). This study compared XCI status in 21 hESC and 10 hiPSC lines and found similar heterogeneity in XCI status in both cell types, varying from no inactivation to partial inactivation or full inactivation. · DOI
  45. Tchieu, J. et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 7, 329–342 (2010). This study looked at XCI status in 30 female hiPSC lines. It reported that these lines display monoclonal status with the inactive X chromosome, although fibroblasts can be mosaic for the XCI. The pattern is inherited in differentiation. During prolonged culture instability in XCI was observed. · DOI · Paper page
  46. Hoffman, L. M. et al. X-inactivation status varies in human embryonic stem cell lines. Stem Cells 23, 1468–1478 (2005). · DOI
  47. Enver, T. et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 14, 3129–3140 (2005). · DOI · Paper page
  48. Shen, Y. et al. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc. Natl Acad. Sci. USA 105, 4709–4714 (2008). · DOI · Paper page
  49. Silva, S. S., Rowntree, R. K., Mekhoubad, S. & Lee, J. T. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc. Natl Acad. Sci. USA 105, 4820–4825 (2008). · DOI · Paper page
  50. Hall, L. L. et al. X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J. Cell. Physiol. 216, 445–452 (2008). · DOI
  51. Allegrucci, C. et al. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum. Mol. Genet. 16, 1253–1268 (2007). · DOI · Paper page
  52. Bibikova, M. et al. Human embryonic stem cells have a unique epigenetic signature. Genome Res. 16, 1075–1083 (2006). · DOI · Paper page
  53. Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genet. 41, 1350–1353 (2009). · DOI · Paper page
  54. Guenther, M. G. et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249–257 (2010). This study characterized genome-wide histone modification patterns and transcriptome profiles in six hESC and six hiPSC lines. It found a high degree of similarity for the both cell types and only few differentially expressed genes. · DOI · Paper page
  55. Hawkins, R. D. et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6, 479–491 (2010). · DOI · Paper page
  56. Ohi, Y. et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nature Cell Biol. 13, 541–549 (2011). · DOI · Paper page
  57. Hong, S. H. et al. Cell fate potential of human pluripotent stem cells is encoded by histone modifications. Cell Stem Cell 9, 24–36 (2011). · DOI
  58. Bar-Nur, O., Russ, H. A., Efrat, S. & Benvenisty, N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet β cells. Cell. Stem Cell. 9, 17–23 (2011). · DOI · Paper page
  59. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68–73 (2011). This study compared whole-genome DNA methylation profiles of five hiPSC lines with hESCs, differentiated hiPSCs and somatic cells. It observed variability between the hiPSC lines and found evidence for somatic memory and aberrant reprogramming inherited in differentiation. · DOI · Paper page
  60. Deng, J. et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotech. 27, 353–360 (2009). · DOI · Paper page
  61. Lengner, C. J. et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141, 872–883 (2010). · DOI · Paper page
  62. Yang, S. et al. Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer 47, 665–679 (2008). · DOI
  63. Moon, S. H. et al. Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. Stem Cell Res. 6, 50–59 (2011). · DOI
  64. An, Q. et al. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc. Natl Acad. Sci. USA 105, 17050–17054 (2008). · DOI
  65. Etemadmoghadam, D. et al. Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer. PLoS ONE 5, e15498 (2010). · DOI
  66. Anastasi, J. et al. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 79, 1796–1801 (1992). · DOI
  67. Richter, A. M., Pfeifer, G. P. & Dammann, R. H. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim. Biophys. Acta 1796, 114–128 (2009).
  68. Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nature Genet. 41, 178–186 (2009). · DOI · Paper page
  69. Herszfeld, D. et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nature Biotech. 24, 351–357 (2006). · DOI
  70. Harrison, N. J. et al. CD30 expression reveals that culture adaptation of human embryonic stem cells can occur through differing routes. Stem Cells 27, 1057–1065 (2009). · doi:10.1002/stem.41
  71. Heins, N. et al. Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22, 367–376 (2004). · DOI · Paper page
  72. Sun, X. et al. Similar biological characteristics of human embryonic stem cell lines with normal and abnormal karyotypes. Hum. Reprod. 23, 2185–2193 (2008). · DOI
  73. Fazeli, A. et al. Altered patterns of differentiation in karyotypically abnormal human embryonic stem cells. Int. J. Dev. Biol. 55, 175–180 (2011). · DOI
  74. Werbowetski-Ogilvie, T. E., Morrison, L. C., Fiebig-Comyn, A. & Bhatia, M. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells 30, 392–404 (2012). · DOI
  75. Mitalipova, M. M. et al. Preserving the genetic integrity of human embryonic stem cells. Nature Biotech. 23, 19–20 (2005). · DOI · Paper page
  76. Biancotti, J. C. et al. Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells 28, 1530–1540 (2010). · DOI
  77. Bock, C. et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nature Biotech. 28, 1106–1114 (2010). · DOI · Paper page
  78. Lund, R. J. et al. High-throughput karyotyping of human pluripotent stem cells. Stem Cell Res. 9, 192–195 (2012). · DOI
  79. Funk, W. D. et al. Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes. Stem Cell Res. 8, 154–164 (2012). · DOI
  80. Hawkins, R. D., Hon, G. C. & Ren, B. Next-generation genomics: an integrative approach. Nature Rev. Genet. 11, 476–486 (2010). · DOI · Paper page
  81. Varela, C. et al. Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells. J. Clin. Invest. 122, 569–574 (2012). · DOI
  82. Moralli, D. et al. An improved technique for chromosomal analysis of human ES and iPS cells. Stem Cell Rev. 7, 471–477 (2011). · DOI
  83. Ku, C. S., Naidoo, N., Wu, M. & Soong, R. Studying the epigenome using next generation sequencing. J. Med. Genet. 48, 721–730 (2011). · DOI
  84. Nichols, J., Evans, E. P. & Smith, A. G. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 110, 1341–1348 (1990). · DOI · Paper page
  85. Longo, L., Bygrave, A., Grosveld, F. G. & Pandolfi, P. P. The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgen. Res. 6, 321–328 (1997). · DOI · Paper page
  86. Liu, X. et al. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev. Dyn. 209, 85–91 (1997). · DOI · Paper page
  87. Sugawara, A., Goto, K., Sotomaru, Y., Sofuni, T. & Ito, T. Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp. Med. 56, 31–34 (2006).
  88. Sommer, C. A. et al. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 28, 64–74 (2010). · DOI · Paper page
  89. Ben-David, U. & Benvenisty, N. High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells 30, 612–622 (2012). · DOI
  90. Pasi, C. E. et al. Genomic instability in induced stem cells. Cell Death Differ. 18, 745–753 (2011). · DOI
  91. Quinlan, A. R. et al. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9, 366–373 (2011). · DOI
  92. Lewis, S. E. et al. Apollo: a sequence annotation editor. Genome Biol. 3, RESEARCH0082 (2002). · DOI · Paper page
  93. Ng, H. H. & Surani, M. A. The transcriptional and signalling networks of pluripotency. Nature Cell Biol. 13, 490–496 (2011). · DOI · Paper page
  94. Inzunza, J. et al. Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol. Hum. Reprod. 10, 461–466 (2004). · DOI
  95. Hovatta, O. et al. A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS ONE 5, e10263 (2010). · DOI
  96. International Stem Cell Initiative. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotech. 25, 803–816 (2007). · DOI · Paper page

Cited by

See all 250

Metadata

Authors
Lund, R. J., Närvä, E., & Lahesmaa, R.
Venue
Nature Reviews Genetics
Published
2012-09-11
Volume
13
Issue
10
Pages
732-744
ISSN
  • 1471-0056 (ISSN-L)
  • 1471-0064
OpenAlex
W2170190422
Cited by
250
References
15
FWCI
1.24
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.